When re-analysing the data by separation of both tumour location subgroups, EGF did not differ between patients with head and neck cancer when compared to patients with lung cancer (p = 1.000) while both groups had significantly higher serum EGF when compared to healthy subjects (p<0.001; Fig 1). Here, EGF is linked to lung carcinoma.